Your Article Summary
See Latest ArticlesNear Full-Length Genome Characterization of an HIV-1 CRF01_AE Strain in Jiangsu, China: Evidence of Two Independent Introductions from Fujian
AIDS Research and Human Retroviruses, 07/01/09
Guo D et al. - Patient JSWX045 had two high-risk behaviors including injection drug use and heterosexual contact. He might have been initially infected with CRF01_AE via heterosexual contact, and then introduced this subtype to other people via injection drug use. Therefore, increasing concern is urgently needed for those persons who often have more than two high-risk behaviors.
Related Articles
HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants
Journal of Leukocyte Biology, 11/12/09
Relevance Score: 84%
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays
Journal of Clinical Virology, 11/11/09
Relevance Score: 84%
The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env
Journal of Virology, 11/11/09
Relevance Score: 84%
Glycoprotein 96-Mediated Presentation of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Human Leukocyte Antigen Class I-Restricted Peptide and Humoral Immune Responses to HIV-1 p24
Clinical and Vaccine Immunology, 11/03/09
Relevance Score: 84%
Retention and Attendance of Women Enrolled in a Large Prospective Study of HIV-1 in the United States
Journal of Women's Health, 10/01/09
Relevance Score: 84%
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09
Lost but Not Forgotten--The Economics of Improving Patient Retention in AIDS Treatment Programs
PLoS Medicine, 12/04/09
Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
PLoS Medicine, 12/04/09